Tumor budding and poorly-differentiated cluster in prognostication in Stage II colon cancer
Author:
Publisher
Elsevier BV
Subject
Cell Biology,Pathology and Forensic Medicine
Reference30 articles.
1. AJCC Cancer Staging Manual 7th edition criteria for colon cancer: do the complex modifications improve prognostic assessment?;Hari;J. Am. Coll. Surg.,2013
2. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer;Benson;J. Clin. Oncol.,2004
3. ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making;Schmoll;Ann. Oncol.,2012
4. Identification of patients with high-risk stage II colon cancer for adjuvant therapy;Quah;Dis. Colon Rectum,2008
5. Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016;Lugli;Mod. Pathol.,2017
Cited by 43 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The prognostic significance of growth pattern, tumor budding, poorly differentiated clusters, desmoplastic reaction pattern and tumor-stroma ratio in colorectal cancer and an evaluation of their relationship with KRAS, NRAS, BRAF mutations;Annals of Diagnostic Pathology;2024-09
2. Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial;Journal of Clinical Oncology;2024-07-31
3. Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts;European Journal of Cancer;2024-07
4. Assessing the applicability and interobserver variability of tumor budding and poorly differentiated clusters in colorectal cancer;Surgical and Experimental Pathology;2024-02-26
5. Tumor Budding, Poorly Differentiated Clusters, and Stroma Percentage in Uterine Endometrioid Carcinomas Are Morphologic Findings Associated With Adverse Clinical Outcomes;International Journal of Gynecological Pathology;2024-02-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3